Chargement en cours...
Effect of discounting on estimation of benefits determined by hepatitis C treatment
The combination of either boceprevir or telaprevir with ribavirin and interferon (triple therapy) has been shown to be more effective than ribavirin+interferon (dual therapy) for the treatment of genotype 1 hepatitis C. Since the benefit of these treatments takes place after years, simulation models...
Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Baishideng Publishing Group Co., Limited
2012
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3380334/ https://ncbi.nlm.nih.gov/pubmed/22736930 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v18.i23.3032 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|